Business
Junior biotech’s shares jump 10% on good news out of the US
Image source: Getty Images
Neurizon Therapeutics Ltd (ASX: NUZ) shares are up more than 10% in early trade after the company said there had been a key development in the US for its lead investigational drug, NUZ-001.
The company stated that the US Food and Drug Administration (FDA) had lifted…
Continue Reading